Nebupent Inhalant
Product Images NDC 63323-877

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nebupent (NDC 63323-877). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Box (Box)

NebuPent inhalant solution label showing the product name and active ingredient pentamidine isethionate. The label indicates a strength of 300 mg per vial, lyophilized for inhalation, preservative free. It is marked Rx only and a single dose vial, labeled by Fresenius Kabi USA, LLC.*

FDA Label Image

Logo (Fklz Address)

FDA Label Image

Nebupent Structure

Chemical structure depicting the molecular formula of Pentamidine Isethionate, the active ingredient in NebuPent 300 mg/6 mL inhalant by Fresenius Kabi USA, LLC.*

FDA Label Image

Vial (Vial)

NebuPent 300 mg per vial inhalant label showing pentamidine isethionate as the active ingredient in a single-dose vial. The label states lyophilized inhalation solution, preservative-free, for use in nebulizer after reconstitution. It includes storage instructions at 20 to 25°C and notes that the product is Rx only. The labeler is Fresenius Kabi USA, LLC with NDC 63323-877.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.